Periodic Fasting, GHR/IGF-1, Multisystem Regeneration, and Healthspan
定期禁食、GHR/IGF-1、多系统再生和健康寿命
基本信息
- 批准号:10374749
- 负责人:
- 金额:$ 47.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-15 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdverse effectsAgeAge-YearsAgingAmino AcidsAnimalsAutoimmuneBeta CellBiological MarkersBone Marrow TransplantationC57BL/6 MouseCardiovascular DiseasesCellsCellular Metabolic ProcessClinical TrialsCognitionCollaborationsCyclic AMP-Dependent Protein KinasesCysteineDataDevelopmental GeneDietDietary InterventionDiseaseFOXO1A geneFastingFemaleFoundationsFundingGasesGenerationsGenesGerontologyGlucoseGoalsGrantGrowthHematopoieticHematopoietic SystemHematopoietic stem cellsHospitalsHumanImmune systemImmunityIn VitroIncidenceIndividualInsulinInsulin-Like Growth Factor IInterventionKetone BodiesLaboratoriesLeadLinkLongevityLyaseMalignant NeoplasmsMediatingMediator of activation proteinMetabolicMetabolic syndromeMitochondriaMolecularMultiple SclerosisMusNatural regenerationNervous system structureNeurodegenerative DisordersNutrientOligodendrogliaOxidative StressPancreasPathway interactionsPatientsPeptidesPeriodicityPharmaceutical PreparationsPositioning AttributeProcessProductionProteinsRandomized Clinical TrialsRegimenRejuvenationReportingResearchResistanceRespirationRisk FactorsRodentRoleSignal TransductionSpinal CordStressSuperoxidesSymptomsSystemTestingToxinTransgenic MiceTranslatingTranslational Researchage relatedbasecognitive enhancementcognitive functioncognitive performancecognitive systemcomplement C2adesigndietary restrictiondisorder riskextracellularfunctional declinehealthspanhuman diseasehuman very old age (85+)humaninimmune system functionimprovedin vitro testingin vivoin vivo evaluationinsightmalemiddle ageneoplastic cellnerve stem cellneurogenesisoverexpressionpreventprogramsprotective effectresiliencestem cell self renewalstem cellssynergismtranslational medicine
项目摘要
PROJECT SUMMARY/ABSTRACT
Age is the major risk factor for many diseases including cancer, cardiovascular and neurodegenerative
disease. Biogerontology research is well positioned to help prevent or at least postpone these diseases by
identifying strategies to delay aging and altering its effects on macromolecular, cellular and extracellular
damage so that the degree and type of damage does not reach the threshold leading to disease incidence or
progression. My laboratory has described the beneficial effect of prolonged fasting and fasting-mimicking diets
in promoting cellular resilience and regeneration and organismal healthspan. The data from the previously
funded PO1 resulted in a recently completed 100 patient randomized clinical trial indicating that a periodic
fasting mimicking diet is effective in reducing risk factors/biomarkers for aging and age-related diseases. Here,
we propose to improve these regimens, test their effect on mouse healthspan, and test the hypothesis that
they promote both cellular protection and stem cell-based regeneration in multiple systems. We will study the
effects of periodic use of a newly designed fasting mimicking diet (FMD5) based on that tested in human
clinical trials and of normocaloric protein restriction cycles (PRC) on the aging of the immune and nervous
systems. An important goal of Project 1 will be to determine whether these periodic dietary interventions can
extend healthspan without exerting adverse effects at very old ages. A major effort will be devoted to the
identification of the molecular mechanisms responsible for the effects of periodic fasting mimicking dietary
interventions on the regeneration of hematopoietic and neural stem cells and whether this regeneration results
in a functional rejuvenation of the immune and nervous systems. We anticipate strong synergism between our
project and Project 2, which will investigate the effects and mechanisms of action of the dietary restriction-
mimicking mitochondrial peptide humanin, and Project 3, which will test the hypothesis that the gas H2S is a
central mediator of fasting-depended protection. We predict that the new insights gained from this project will
continue to be translated into clinical trials to identify interventions that are safe and effective in improving
human healthspan.
项目总结/摘要
年龄是许多疾病的主要风险因素,包括癌症、心血管疾病和神经退行性疾病。
疾病生物老年学研究很好地帮助预防或至少推迟这些疾病,
确定延缓衰老的策略,并改变其对大分子、细胞和细胞外的影响
损害程度和损害类型未达到导致疾病发生的阈值,或
进展我的实验室已经描述了长期禁食和禁食模仿饮食的有益效果
在促进细胞恢复和再生以及有机体健康方面。以前的数据
一项最近完成的100例患者随机临床试验表明,
禁食模仿饮食可有效减少衰老和年龄相关疾病的风险因素/生物标志物。在这里,
我们建议改进这些方案,测试它们对小鼠健康寿命的影响,并测试以下假设:
它们在多个系统中促进细胞保护和基于干细胞的再生。我们会研究
根据人体试验结果,定期使用新设计的禁食模拟饮食(FMD 5)的效果
临床试验和热量正常的蛋白质限制周期(PRC)对免疫和神经老化的影响
系统.项目1的一个重要目标是确定这些定期饮食干预是否可以
延长健康寿命,而不会对老年人产生不利影响。将作出重大努力,
确定负责周期性禁食模仿饮食影响的分子机制
对造血干细胞和神经干细胞再生的干预,以及这种再生是否会导致
免疫系统和神经系统的功能恢复。我们期待着我们之间的强大协同作用,
项目2将调查饮食限制的影响和作用机制,
模拟线粒体肽humanin,和项目3,这将测试的假设,气体H2S是一个
禁食依赖性保护的中心介质。我们预测,从这个项目中获得的新见解将
继续转化为临床试验,以确定安全有效的干预措施,
人类健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALTER D. LONGO其他文献
VALTER D. LONGO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALTER D. LONGO', 18)}}的其他基金
Periodic Fasting, GHR/IGF-1, Multisystem Regeneration, and Healthspan
定期禁食、GHR/IGF-1、多系统再生和健康寿命
- 批准号:
10816720 - 财政年份:2018
- 资助金额:
$ 47.04万 - 项目类别:
"Interventions to Slow Aging in Humans: Are We Ready?"
“减缓人类衰老的干预措施:我们准备好了吗?”
- 批准号:
8597898 - 财政年份:2013
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8018805 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-l & Mechanisms of Cellular Protection and Regeneration
饮食限制,GH/IGF-l
- 批准号:
9074571 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8240033 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8816020 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8643557 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
Dietary Restriction, GH/IGF-I & Mechanisms of Differential Cellular Protection
饮食限制,GH/IGF-I
- 批准号:
8429461 - 财政年份:2011
- 资助金额:
$ 47.04万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 47.04万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 47.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 47.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 47.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 47.04万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




